Where does Dragonfly Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Dragonfly Therapeutics, Inc. ranks #19,683 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Dragonfly Therapeutics, Inc. hold?

Dragonfly Therapeutics, Inc. holds 14 US utility patents granted between 2023 and 2025, spanning 3 technology areas.

What is Dragonfly Therapeutics, Inc.'s Innovation Score?

Dragonfly Therapeutics, Inc. has an Innovation Score of 46.2 out of 100 (top 21% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Dragonfly Therapeutics, Inc. focus on?

Dragonfly Therapeutics, Inc.'s top technology area is C07K (Peptides) with 14 patents, ranking #671 of 3,615 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Dragonfly Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Dragonfly Therapeutics, Inc..

What does claim depth mean for Dragonfly Therapeutics, Inc.'s patents?

Dragonfly Therapeutics, Inc.'s patents average 17.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Dragonfly Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Dragonfly Therapeutics, Inc.

USPTO PatentsView assignee record - 14 granted patents across 3 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Dragonfly ranks #19,683 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 3 technology areas.

#19,683
of 49,997 US assignees by volume: Top 21%
by Innovation Score (46.2/100): 17.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R19683 · US Corporation #19,683 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 14 grants
MID-PACK #19,683/49,997
PHOTO-FINISH Dongguan Yongxiang…
CPC-NARROW C07K · 3 areas
INNOV-PAR 46.2/100
CLAIMS-RICH 17.9 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Dongguan Yongxiang plastic products Co., Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Dragonfly’s 46.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (20%) Velocity 20.0 pts (43%) Breadth 6.1 pts (13%) Claim depth 10.7 pts (23%)

Qualcomm Incorporated · highest

85
Dragonfly Therapeutics · this assignee

46
3D Lighting… · lowest

7

What this shows Dragonfly's Innovation Score is 46.2/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Dragonfly?

Each dot is one of Dragonfly’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dragonfly’s own 17.9 claims/patent is ABOVE the 17.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Dragonfly vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Dragonfly's grants concentrate

Dragonfly Therapeutics, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2024 (5 grants) versus a trough of 2 in 2023. By volume, Dragonfly sits between Dongguan Yongxiang plastic products Co., Ltd and E-Z Products LLC.

Dragonfly's three-year grant acceleration

Dragonfly Therapeutics, Inc. shows 7 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Dongguan Yongxian…

14
Doppstadt Familie…

14
Doro AB

14
Dot Hill Systems

14
Driverdo

14
Drone Delivery Ca…

14
Dynamic Material…

14
E-Z Products

14
Dragonfly Therape… ◀

14

What this shows Dragonfly holds 14 patents at rank #19,686, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Dragonfly

By rank, the assignees closest to #19,686 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Dragonfly's primary technology class.

Dragonfly's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 21% higher than 79% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Dragonfly Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	2	14.3%
2024	5	35.7%
2025partial year	7	50.0%

Which technologies does Dragonfly Therapeutics, Inc. patent most?

C07K - Peptides 14

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 13

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Dragonfly Therapeutics, Inc.'s patent record in context - here's where to go next.

Dragonfly Therapeutics, Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #19,683 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Dragonfly Therapeutics, Inc. against Dongguan Yongxiang plastic products Co., Ltd, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.